Stem Cell Institute Philippines

novel inductions for the future...

Stem Cell News




Streaming NIH Database of the Latest in Stem Cell Research:

Here is a streaming database from the NIH for your own Education and Research:
Related Articles Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease. Drugs. 2017 Nov 14;: Authors: Bermejo F, Guerra I, Algaba A, López-Sanromán A Abstract Perianal localization of Crohn's disease involves significant morbidity, affects quality of life and results in an increased use of healthcare resources. Medical and surgical therapies contribute to its management. The objective of this review is to address the current understanding in the management of perianal Crohn's disease, with the main focus in reviewing pharmacological therapies, including stem cells. In complex fistulas, once local sepsis has been controlled by surgical drainage and/or antibiotics, anti-TNF drugs (infliximab, adalimumab) are the first-line therapy, with or without associated immunomodulators. Combining surgery and anti-TNF therapy has additional benefits for healing. However, response is inadequate in up to half of cases. A possible role of new biological drugs in this context (vedolizumab, ustekinumab) is an area of ongoing investigation, as is the local application of autologous or allogeneic mesenchymal stem cells. These are non-hematopoietic multipotent cells with anti-inflammatory and immunomodulatory properties, the use of which may successfully treat refractory patients, and seem to be a promising and safe alternative to achieving fistula healing in Crohn's disease, without known systemic effects. PMID: 29139091 [PubMed - as supplied by publisher]